Skip to the articles
Attorney Directory

Pharmaceutical Product Liability in Georgia

Published 12 authorities named

A Georgia prescription drug claim runs against the drug’s manufacturer, but three filters decide whether it can proceed: whether the drug was brand-name or generic, what the prescribing doctor was told and would have done, and the time limits. A generic drug’s label is largely protected by federal law. A brand-name maker has to warn the doctor adequately, and if it did, or if the doctor would have prescribed anyway, the claim can fail.

Brand or generic: what federal law leaves open

Find out which product was dispensed first. The pharmacy record shows it.

Claim Brand-name Generic
Failure to warn Survives under Wyeth v. Levine, absent clear evidence the FDA would have refused Preempted under PLIVA v. Mensing
Design claim turning on warnings Georgia's own test applies Preempted under Mutual Pharmaceutical v. Bartlett
Batch that departs from approved specifications Available in principle Not what those decisions decided, so have counsel read it

The reasoning is on federal preemption. A patient on a generic drug may also ask about the brand-name company that wrote the original label. Georgia strict liability under § 51-1-11(b)(1) reaches the manufacturer of the property sold, so a company that didn’t make those pills is a hard target on that theory. Other theories would need separate analysis.

The doctor’s role

Georgia uses the learned intermediary rule. “Ordinarily, in the case of prescription drugs, a warning as to possible danger in its use to the prescribing physician is sufficient”, said Presto v. Sandoz Pharmaceuticals, 226 Ga. App. 547 (1997). There, a patient on Clozaril stopped taking it and later died by suicide, and the claim that the family wasn’t warned directly failed. The doctor had signed that he was familiar with the package information.

Causation can decide the case. In Dietz v. SmithKline Beecham, 598 F.3d 812 (11th Cir. 2010), applying Georgia law to Paxil, the doctor testified that he would have prescribed it anyway, even with the warnings the plaintiff wanted. That “severs any potential chain of causation”. So the prescriber’s deposition may decide the case. The learned intermediary doctrine gives the full rule.

Design claims against a drug

Bryant v. Hoffmann-La Roche, 262 Ga. App. 401 (2003), is the main Georgia decision. A patient took Posicor with a beta blocker and suffered severe brain injuries. The company urged the California rule, which would shield prescription drugs from design defect claims altogether. The Court of Appeals declined. A special concurrence described the majority’s test as “a case-by-case application of comment k as an affirmative defense in conjunction with risk-utility analysis”. Comment k is the Restatement note on products that can’t be made fully safe. The result was a reversal in part, including a live question on whether the insert’s warnings were sufficient. The patient’s implied warranty claim failed for lack of privity with the maker.

What the proof looks like

Element Evidence Note
Which product, and when Pharmacy records, prescription history Brand or generic, lot if known
What the label said Label in force on the dates of use Labels change
What the maker knew Studies, adverse event data, internal files Discovery
What the doctor read Doctor's testimony, chart Causation
General causation Scientific literature, an expert § 24-7-702 gate
Specific causation Treating records, an expert Other causes must be addressed

An expert must qualify under § 24-7-702. In Stubbs v. Home Depot, A26A0824 (2026), a trial court’s exclusion of an expert without the right kind of experience was upheld, and that’s a lawnmower case. It shows how much rides on the choice. Expert disclosures describes the gate.

Other complaints and FDA adverse event reports help only if they meet the “substantial similarity” rule of Cooper Tire v. Crosby, 273 Ga. 454 (2001), or another route for notice. Be careful not to treat an FDA report as proof that the drug caused the event.

Pharmacy and doctor claims are different

A pharmacy that fills a prescription isn’t the manufacturer. In Robinson v. Williamson, 245 Ga. App. 17 (2000), the court held that “a pharmacist and pharmacy that package and label drugs manufactured by another are product sellers, not manufacturers”. Claims about a wrong drug or a dosing error may need the expert affidavit and time limits of a malpractice claim, as pharmacy errors explains. A doctor’s choice of drug raises its own issue, and that isn’t a product claim.

Time limits

Two years. § 9-3-33 sets two years for injury, and its text says nothing about discovery. Georgia has a limited judicial discovery rule. Corporation of Mercer University v. National Gypsum, 258 Ga. 365 (1988), confined it “to cases of bodily injury which develop only over an extended period of time”. A sudden reaction doesn’t fit that. A slowly developing condition might, so get advice on the exact dates.

Ten years. Under § 51-1-11(b)(2), strict liability actions end ten years “from the date of the first sale for use or consumption”. For drugs bought repeatedly, Burroughs v. Strength of Nature Global, 322 Ga. 722 (2025), applied repose “on a per-unit basis” to a hair product, leaving open what happens if units sold outside the period contributed to the injury.

Disease and birth defect. Under § 51-1-11(c), the ten-year limit on negligence claims doesn’t apply to negligence “in manufacturing products which cause a disease or birth defect”. That exception concerns negligence, not strict liability. The duty to warn of a danger once known also isn’t cut off. The repose exceptions walks through this.

Multidistrict litigation and damages

Claims about one drug pending in different districts may be sent to one federal court for pretrial work under 28 U.S.C. § 1407. A Georgia case can then be moved out of state for that stage, and a remand back at the end is provided for. Punitive damages in a product case have no cap under § 51-12-5.1(e)(1), only one award per act or omission is allowed, and 75 percent goes to the state under (e)(2). The evidence must be clear and convincing under (b).

What to keep and write down

  1. Keep the container, package insert, and pharmacy receipts.
  2. Get pharmacy and prescribing records.
  3. Don’t stop or change medicine because of a legal question. Ask your doctor.
  4. Write the dates: first dose, symptoms, diagnosis, and when anyone linked the two.
  5. Report the event to your doctor, and note any recall you were told about.

Sources

This page was last reviewed in November 2026 for general information. Laws and court decisions can change after that date. It is not legal advice and does not create an attorney-client relationship.

More on: Defective product

Authorities cited

Georgia code

  • O.C.G.A. § 51-1-11
  • O.C.G.A. § 24-7-702
  • O.C.G.A. § 9-3-33
  • O.C.G.A. § 51-12-5.1

Court decisions

  • Presto v. Sandoz Pharmaceuticals, 226 Ga. App. 547
  • Dietz v. SmithKline Beecham, 598 F.3d 812
  • Bryant v. Hoffmann-La Roche, 262 Ga. App. 401
  • Stubbs v. Home Depot, A26A0824
  • Cooper Tire v. Crosby, 273 Ga. 454
  • Robinson v. Williamson, 245 Ga. App. 17
  • Corporation of Mercer University v. National Gypsum, 258 Ga. 365
  • Burroughs v. Strength of Nature Global, 322 Ga. 722

Every source, with its link

Reader comments

Leave a Reply

Your email address will not be published. Required fields are marked *